Skip to Main Content
Yale Institute for Global Health
Yale Home

INFORMATION FOR

    Mental Health & Behavioral Research

    Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

    What is the purpose of this trial?

    This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.

    • Ages
      21 years - 55 years
    • Gender
      Both
    Find out more about who can participate in this trial

    Contact Information

    For more information about this study, including how to volunteer, contact Study Team

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    Create a volunteer profile

    Principal Investigator

    Sub-Investigators

    • Last Updated
      11/23/2025
    • Study IRB
      #2000020355

    Contact Information

    For more information about this study, including how to volunteer, contact Study Team